Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intravenous hydrocortisone in sepsis
TCTR20231026001Phase 3Unknown
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in sepsis, septic shock, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Status: unknown.
02
Drugs
hydrocortisone
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on TCTR20231026001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231026001.